SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX)
AFFX 14.010.0%Apr 1 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (1594)1/29/2003 7:00:38 PM
From: lnkennedy  Read Replies (1) of 1728
 
Earnings are out: Up 20% Q4 and 29% YOY, not bad in a sluggish time.



Affymetrix 4Q EPS 5c

DOW JONES NEWSWIRES

Affymetrix Inc. - Santa Clara, Calif.
4th Quar Dec. 31:
2002 2001
Revenue $78,299,000 $65,073,000
Net income a 2,916,000 (8,446,000)
Avg shrs (diluted) 60,460,000 57,683,000
Shr earns
Net income a .05 (.15)
Year:
Revenue 289,874,000 224,874,000
Net income b (1,630,000) c (33,121,000)
Avg shrs (diluted) 58,018,000 57,382,000
Shr earns
Net income b (.03) c (.58)
Figures in parentheses are losses.

a. Excluding non-cash stock compensation expense and amortization of purchased intangible assets, the company had pro forma net income of $4 million, or 7 cents a diluted share.

b. Excluding non-cash stock compensation expense, amortization of purchased intangible assets and a litigation settlement in 2001, the company reported a pro forma profit of $7.9 million or 13 cents a diluted share.

c. Excluding items, the company reported a pro forma net loss of $9.7 million, or 17 cents a diluted share
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext